Bryant Fong - Aug 22, 2023 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Bryant Fong
Stock symbol
ADMA
Transactions as of
Aug 22, 2023
Transactions value $
-$5,544,737
Form type
4
Date filed
8/23/2023, 08:30 PM
Previous filing
Mar 8, 2023
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Sale -$5.54M -1.43M -100% $3.87 0 Aug 22, 2023 See footnote F1, F2
holding ADMA Common Stock 59.9K Aug 22, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of sales on August 22, 2023. The shares were sold in multiple transactions at prices ranging from $3.81 to $3.99, inclusive.
F2 Represents shares sold by Biomark Capital Fund ("Biomark Capital"). Mr. Fong is a Managing Director and General Partner at Biomark Capital and may have been deemed the beneficial owner of such shares.
F3 Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date; and (ii) 34,086 shares of common stock owned by the reporting person.